Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Holiday shoppers look for “For Sale” signs, while those shopping during Thanksgiving seek out bargains. In retail, a reduction in price is an invitation to act.
ISRG faces rising pricing pressure in China as local rivals gain ground, but its ecosystem, local manufacturing and disciplined pricing aim to defend its position.
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $460.99, representing a +1.81% change from its previous close.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $471.91, signifying a -1.28% move from its prior day's close.
ISRG records 37% margins despite tariff pressure, using cost efficiencies and recurring revenue strength to offset headwinds and sustain profitability.
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ISRG targets fast-growing ambulatory surgery centers with lower-cost da Vinci systems, positioning for long-term procedure growth as care shifts beyond hospitals.
Bamco Inc. NY lessened its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,633 shares of the medical equipment provider's stock after selling 1,140 shares during the quarter.
Ameriprise Financial Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,674,479 shares of the medical equipment provider's stock after acquiring an additional 19,552